Tobramycin
Product Images NDC 0093-3750

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 0093-3750). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

1 (Image 1)
Chemical structure of Tobramycin showing the arrangement of amino and hydroxyl groups on its sugar rings.*
FDA Label Image

1 (Image 10)

1 (Image 10)
An instructional diagram showing the assembly of a nebulizer device. The image illustrates attaching a vial or ampule to the nebulizer cup, which has a mouthpiece and a handle, indicating how to prepare the device for medication delivery.*
FDA Label Image

1 (Image 11)

1 (Image 11)
An instructional diagram showing a component assembly of an inhaler device, where a circular piece is aligned above the opening of the inhaler chamber with a handle on the side. The illustration highlights placement of the top piece onto the chamber.*
FDA Label Image

1 (Image 12)

1 (Image 12)
An instructional illustration showing a hand plugging in a cord to a Vios nebulizer device. The image focuses on the back panel of the nebulizer, highlighting the power input and the power switch on the device labeled with 'Replace Neb Cup' instructions.*
FDA Label Image

1 (Image 13)

1 (Image 13)
An instructional line drawing showing a hand unplugging a two-prong electrical plug from a wall outlet. The image emphasizes safe disconnection of electrical devices by grasping the plug firmly before removal.*
FDA Label Image

1 (Image 14)

1 (Image 14)
An instructional line drawing of a nebulizer device used for inhalation therapy, showing airflow direction through the mouthpiece and medicine chamber. The illustration depicts the components and flow path typical for aerosol delivery systems.*
FDA Label Image

1 (Image 15)

1 (Image 15)
An instructional illustration showing a hand pressing a button on a Vios nebulizer device, used for delivering aerosolized medication such as Tobramycin. The device has labels indicating function, including 'Replace Neb Cup' and a power switch.*
FDA Label Image

1 (Image 16)

1 (Image 16)
An illustration showing the use of an inhaler device, with a hand holding the inhaler and mist being released from the mouthpiece.*
FDA Label Image

1 (Image 17)

1 (Image 17)
An instructional illustration showing the use of a nebulizer device delivering inhalation medication into a human nasal passage. The diagram highlights the device positioned at the entrance of the nose, directing aerosolized medication into the nasal airway.*
FDA Label Image

Carton (Image 18)

Carton (Image 18)
Packaging label for Tobramycin Inhalation Solution, USP 300 mg/4 mL by Teva Pharmaceuticals USA, Inc. The label is for 28 single-dose ampules, intended for oral inhalation by nebulizer, with instructions to discard each ampule after one use. The label includes storage instructions and is marked for prescription use only.*
FDA Label Image

1 (Image 2)

1 (Image 2)
Line graph showing the predicted percentage change from baseline in FEV1 over 24 weeks comparing Tobramycin Inhalation Solution versus placebo in two separate studies with different sample sizes. The x-axis represents time in weeks, and the y-axis represents FEV1 percentage change.*
FDA Label Image

1 (Image 3)

1 (Image 3)
An instructional diagram showing the components of a Tobramycin inhalation treatment setup. It includes a PARI LC PLUS reusable nebulizer with labeled parts such as the inspiratory valve cap, nebulizer cup top, and nebulizer cup, a mouthpiece, one ampule of Tobramycin Inhalation Solution USP, a nose clip, tubing, a clean paper towel, and a PARI Vios compressor device.*
FDA Label Image

1 (Image 4)

1 (Image 4)
Tobramycin 300 mg/5 mL inhalation solution in unit-dose ampules by Teva Pharmaceuticals USA, Inc. The image shows a foil pouch containing five plastic ampules labeled for inhalation use. The label includes storage instructions and manufacturing details, including that it is made in England and marketed by Teva Pharmaceuticals USA. A barcode and NDC number 0093-3750 are visible.*
FDA Label Image

1 (Image 5)

1 (Image 5)
An instructional line drawing showing hands twisting or opening two single-dose vials of Tobramycin oral solution. The image demonstrates the method to prepare or access the liquid medication before use. No text other than vial outlines is visible.*
FDA Label Image

1 (Image 6)

1 (Image 6)
An instructional illustration showing two hands holding a Tobramycin single-use vial, demonstrating how to grasp and prepare the vial for use. The vial label is partially visible, indicating it is a medication container.*
FDA Label Image

1 (Image 7)

1 (Image 7)
An instructional line drawing demonstrating the assembly or use of a Tobramycin nebulizer cup. The diagram shows hands holding the nebulizer cup with labeled parts including the nebulizer cup top and outlet, along with directional arrows indicating movements for assembly or operation.*
FDA Label Image

1 (Image 8)

1 (Image 8)
An instructional illustration depicting two hands preparing a nebulizer for use by holding a vial of Tobramycin oral inhalation solution and pouring the medication into the nebulizer cup. The image demonstrates the medication administration step for inhalation therapy.*
FDA Label Image

1 (Image 9)

1 (Image 9)
An instructional illustration showing hands assembling a nebulizer device for Tobramycin. The diagram labels the nebulizer cup top and nebulizer cup outlet, with arrows indicating the order of assembly by aligning the cup top onto the cup outlet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.